These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 9690438)

  • 1. Fetal malformation and failed medical termination of pregnancy.
    Sitruk-Ware R; Davey A; Sakiz E
    Lancet; 1998 Jul; 352(9124):323. PubMed ID: 9690438
    [No Abstract]   [Full Text] [Related]  

  • 2. Toxic epidermal necrolysis after mifepristone/gemeprost-induced abortion.
    Lecorvaisier-Pieto C; Joly P; Thomine E; Tanasescu S; Noblet C; Lauret P
    J Am Acad Dermatol; 1996 Jul; 35(1):112. PubMed ID: 8682946
    [No Abstract]   [Full Text] [Related]  

  • 3. Mortality associated with mifepristone-misoprostol medical abortion.
    Creinin M; Blumenthal P; Shulman L
    MedGenMed; 2006 Apr; 8(2):26. PubMed ID: 16926765
    [No Abstract]   [Full Text] [Related]  

  • 4. Rupture in an unscarred uterus during second trimester pregnancy termination with mifepristone and misoprostol.
    Bagga R; Chaudhary N; Kalra J
    Int J Gynaecol Obstet; 2004 Oct; 87(1):42-3. PubMed ID: 15464778
    [No Abstract]   [Full Text] [Related]  

  • 5. Möbius syndrome in a neonate after mifepristone and misoprostol elective abortion failure.
    Bos-Thompson MA; Hillaire-Buys D; Roux C; Faillie JL; Amram D
    Ann Pharmacother; 2008 Jun; 42(6):888-92. PubMed ID: 18460590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Reintroduction of medical abortion in Denmark].
    Olsen CD; Wittendorff HE; Jørgensen JJ
    Ugeskr Laeger; 2000 Mar; 162(12):1742-4. PubMed ID: 10766656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for unsuccessful medical abortion with mifepristone and misoprostol.
    Haimov-Kochman R; Arbel R; Sciaky-Tamir Y; Brzezinski A; Laufer N; Yagel S
    Acta Obstet Gynecol Scand; 2007; 86(4):462-6. PubMed ID: 17486469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is there evidence to decrease the approved dose of 600 mg of mifepristone for medical abortion?
    Lièvre M; Sitruk-Ware R
    Contraception; 2010 Jun; 81(6):553-4. PubMed ID: 20472128
    [No Abstract]   [Full Text] [Related]  

  • 9. Early pregnancy termination with mifepristone and misoprostol in the United States.
    Spitz IM; Bardin CW; Benton L; Robbins A
    N Engl J Med; 1998 Apr; 338(18):1241-7. PubMed ID: 9562577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Termination of pregnancy at 9-13 weeks' amenorrhoea with mifepristone and misoprostol.
    Ashok PW; Flett GM; Templeton A
    Lancet; 1998 Aug; 352(9127):542-3. PubMed ID: 9716062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medical abortion for adolescents.
    Grimes DA; Raymond EG
    BMJ; 2011 Apr; 342():d2185. PubMed ID: 21508043
    [No Abstract]   [Full Text] [Related]  

  • 12. Randomised controlled trial comparing the efficacy of same-day administration of mifepristone and misoprostol for termination of pregnancy with the standard 36 to 48 hour protocol.
    Guest J; Chien PF; Thomson MA; Kosseim ML
    BJOG; 2007 Feb; 114(2):207-15. PubMed ID: 17305893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Mifepristone for induction of second trimester abortion].
    Heimstad R; Backe B
    Tidsskr Nor Laegeforen; 2003 Sep; 123(17):2412-3. PubMed ID: 14560764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concurrent use of mifepristone and misoprostol for early medical abortion.
    Li YT; Chen FM; Chen TH; Li SC; Chen ML; Kuo TC
    Taiwan J Obstet Gynecol; 2006 Dec; 45(4):325-8. PubMed ID: 17175491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pre-emptive effect of ibuprofen versus placebo on pain relief and success rates of medical abortion: a double-blind, randomized, controlled study.
    Avraham S; Gat I; Duvdevani NR; Haas J; Frenkel Y; Seidman DS
    Fertil Steril; 2012 Mar; 97(3):612-5. PubMed ID: 22265034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two mifepristone doses and two intervals of misoprostol administration for termination of early pregnancy: a randomised factorial controlled equivalence trial.
    von Hertzen H; Piaggio G; Wojdyla D; Marions L; My Huong NT; Tang OS; Fang AH; Wu SC; Kalmar L; Mittal S; Erdenetungalag R; Horga M; Pretnar-Darovec A; Kapamadzija A; Dickson K; Anh ND; Tai NV; Tuyet HT; Peregoudov A;
    BJOG; 2009 Feb; 116(3):381-9. PubMed ID: 19187370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reviewer's commentary on 'Continuation of pregnancy after first-trimester exposure to mifepristone: an observational prospective study'.
    Cameron S
    BJOG; 2013 Apr; 120(5):575. PubMed ID: 23599962
    [No Abstract]   [Full Text] [Related]  

  • 18. Medical abortion: a fact sheet.
    Berer M
    Reprod Health Matters; 2005 Nov; 13(26):20-4. PubMed ID: 16366018
    [No Abstract]   [Full Text] [Related]  

  • 19. Use of mifepristone and sublingual misoprostol for early medical abortion.
    Lin M; Li YT; Chen FM; Wu SF; Tsai CW; Chen TH; Kuo TC
    Taiwan J Obstet Gynecol; 2006 Dec; 45(4):321-4. PubMed ID: 17175490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Medical abortion--the first Norwegian experiences].
    Iversen OE; Midbøe G; Johnsen SL; Augestad G; Økland I; Helland H; Strray-Pedersen S; Bjørge L
    Tidsskr Nor Laegeforen; 2003 Sep; 123(17):2422-4. PubMed ID: 14594047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.